XERS- Xeris Biopharma Holdings, Inc.

Insider activity in XERS over the last quarter tilts toward selling: insiders offloaded a net 16,667 shares worth roughly $101K.

XERS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Shannon John Patrick Jr	3.16M	$26.50M	-
Other	McCulloch Kevin	1.79M	$14.98M	-
Other	Pieper Steven	1.46M	$12.26M	-
Other	Hecht Beth	1.18M	$9.87M	-
Dir	Johnson John	698.1K	$5.86M	-

Buys and sells only

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 14, 2024	Schmid John P.80	Director	Buy	4,500	$2.16	$9,720.00	+69.2%	+5.2%	+126.3%
Nov 27, 2023	Sherman Jeffrey W	Director	Buy	5,400	$1.87	$10,098.00	New	+69.0%	+72.8%
Nov 20, 2023	Pieper Steven	See Remarks	Buy	28,000	$1.95	$54,600.00	+2.4%	+73.6%	+65.4%
Nov 20, 2023	Halkuff Dawn	Director	Buy	5,410	$1.84	$9,954.40	New	+73.6%	+65.4%
Nov 17, 2023	Shannon John Patrick Jr53	See Remarks	Buy	30,769	$1.64	$50,399.62	+2.2%	+81.4%	+65.0%
Nov 16, 2023	Schmid John P.80	Director	Buy	6,500	$1.51	$9,815.00	New	+104.5%	+86.0%
Nov 14, 2023	Persky Marla	Director	Buy	6,370	$1.58	$10,057.59	New	+89.1%	+101.9%
Aug 9, 2023	Edick Paul R	See Remarks	Buy	10,000	$2.38	$23,794.00	+0.4%	-20.2%	-5.1%
Dec 13, 2022	Edick Paul R	See Remarks	Buy	20,000	$1.45	$29,000.00	+1.3%	-14.2%	+50.4%
May 12, 2022	Edick Paul R	See Remarks	Buy	100,000	$1.40	$140,380.00	+7.1%	+27.0%	+90.8%